Latest news

News archive

CTO Adam Feiler on NLAB Spiro – The Next Generation Drug Carrier for Inhaled Formulations

9 March, 2021

Introducing Mr. PK Dutta, PhD – Nanologica’s SVP Sales and Senior Advisor for Chromatography

1 March, 2021

Nanologica’s SVP Sales and Senior Advisor for Chromatography, Mr. PK Dutta, PhD in a discussion with CEO Andreas Bhagwani regarding his new appointment and his view on the peptide/preparative chromatography market: Watch the interview

Nanologica’s CEO Andreas Bhagwani presents the year-end report 2020

26 February, 2021

Nanologicas vd Andreas Bhagwani presenterar bokslutskommunikén 2020

26 February, 2021

Interview in Penserpodden

11 February, 2021

CEO Andreas Bhagwani interviewed in Erik Penser Bank’s podcast Penserpodden. Available on this link and on Spotify.

Job Opening – Process Chemist

10 February, 2021

We are currently looking for a Process Chemist who likes to solve problems and develop optimised ways of working. You will work closely with our manufacturing unit, but it is R&D that is hosting this position. Formulation and chemical modification are key words! Read more about the job and how to apply here: Job advertisement Process Chemist at Nanologica Last application date: Feb 25, 2021.

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.